Nymox Pharmaceutical Corporation (NYMX): Price and Financial Metrics
GET POWR RATINGS... FREE!
NYMX POWR Grades
- NYMX scores best on the Sentiment dimension, with a Sentiment rank ahead of 65.34% of US stocks.
- NYMX's strongest trending metric is Momentum; it's been moving down over the last 44 weeks.
- NYMX ranks lowest in Value; there it ranks in the 10th percentile.
NYMX Stock Summary
- NYMX's price/sales ratio is 32,275.92; that's higher than the P/S ratio of 99.86% of US stocks.
- With a year-over-year growth in debt of 189.8%, Nymox Pharmaceutical Corp's debt growth rate surpasses 95.24% of about US stocks.
- As for revenue growth, note that NYMX's revenue has grown -97.77% over the past 12 months; that beats the revenue growth of merely 0.92% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Nymox Pharmaceutical Corp are INMB, MRSN, CVM, ZOM, and CALT.
- NYMX's SEC filings can be seen here. And to visit Nymox Pharmaceutical Corp's official web site, go to www.nymox.com.
NYMX Valuation Summary
- In comparison to the median Healthcare stock, NYMX's price/earnings ratio is 138.9% lower, now standing at -14.2.
- Over the past 243 months, NYMX's EV/EBIT ratio has gone up 8.9.
- NYMX's price/sales ratio has moved up 32812.5 over the prior 243 months.
Below are key valuation metrics over time for NYMX.
NYMX Growth Metrics
- The 2 year price growth rate now stands at 15.23%.
- Its 4 year revenue growth rate is now at -98.24%.
- Its 2 year net cashflow from operations growth rate is now at -28.66%.
The table below shows NYMX's growth in key financial areas (numbers in millions of US dollars).
|Date||Revenue||Operating Cash Flow||Net Income to Common Stock|
NYMX Stock Price Chart Interactive Chart >
NYMX Price/Volume Stats
|Current price||$2.02||52-week high||$3.50|
|Prev. close||$2.08||52-week low||$1.25|
|Day high||$2.09||Avg. volume||294,583|
|50-day MA||$1.84||Dividend yield||N/A|
|200-day MA||$2.10||Market Cap||166.41M|
Nymox Pharmaceutical Corporation (NYMX) Company Bio
Nymox Pharmaceutical Corporation engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimers disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in Phase III clinical trials for the treatment of enlarged prostate or benign prostatic hyperplasia, as well as is in Phase II clinical trial for low grade localized prostate cancer. The company was founded in 1989 and is based in Nassau, The Bahamas.
Most Popular Stories View All
NYMX Latest News Stream
|Loading, please wait...|
NYMX Latest Social Stream
View Full NYMX Social Stream
Latest NYMX News From Around the Web
Below are the latest news stories about Nymox Pharmaceutical Corp that investors may wish to consider to help them evaluate NYMX as an investment opportunity.
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI ) (IPOed Thursday) Arvinas, Inc. (NASDAQ: ARVN ) BioNTech SE (NASDAQ: BNTX ) ( disclosed plans to make mRNA vaccine for malaria by 2022) Cassava Sciences, Inc. (NASDAQ: SAVA ) (announced positive data for SavaDx, an investigational diagnostic/biomarker to detect Alzheimer''s disease with a simple blood test) Eli Lilly and Company (NYSE: LLY ) Moderna, Inc. (NASDAQ: MRNA ) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) NanoVibronix, Inc. (NASDAQ: NAOV ) (announced first shipment of its next generation pain management device, PainShield Plus) Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) Sight Sciences, Inc. (NASDAQ: SGH...
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) - U.K. antitrust regulators cleared its pending acquisition by AstraZeneca PLC (NASDAQ: AZN ) Bristol-Myers Squibb Company (NYSE: BMY ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Moderna, Inc. (NASDAQ: MRNA ) PLx Pharma Inc. (NASDAQ: PLXP ) Zoetis Inc. (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 14) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 89bio, Inc. (NASDAQ: ETNB ) AbCellera Biologics Inc. (NASDAQ: ABCL ) Achilles Therapeutics plc (NASDAQ: ACHL ) Adicet Bio, Inc. (NASDAQ: ACET ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Akero Therapeutics, Inc. (NASDAQ: A...
The Daily Biotech Pulse: ScPharma''s Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical Holding Company Ltd. . (NYSE: BHVN ) AngioDynamics, Inc. (NASDAQ: ANGO ) (reacted to its fiscal-year 2021 fourth-quarter results) Bicycle Therapeutics plc (NASDAQ: BCYC ) ( announced Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ) exercised option to use its tissue-targeted delivery of oligonucleotide therapeutics tech) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Forward Pharma A/S (NASDAQ: FWP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) PLx Pharma Inc. (NASDAQ: PLXP ) (announced availability of FDA-approved liquid-filled aspirin capsules in Walmart Inc. (NYSE: WMT ) stores) Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX ) U...
InvestorPlace is starting the day off right by checking out the biggest pre-market stock movers, including the winners and losers.
NYMX Price Returns
Continue Researching NYMXHere are a few links from around the web to help you further your research on Nymox Pharmaceutical Corp's stock as an investment opportunity:
Nymox Pharmaceutical Corp (NYMX) Stock Price | Nasdaq
Nymox Pharmaceutical Corp (NYMX) Stock Quote, History and News - Yahoo Finance
Nymox Pharmaceutical Corp (NYMX) Stock Price and Basic Information | MarketWatch